FDA Moves to Modernize Inspections for Sterile Injectables

International Pharmaceutical Regulatory Monitor
A A
The FDA is streamlining its reporting of inspections for sterile injectable drugs to help make risk-based regulatory decisions.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00